#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Da Vinci assisted surgery for rectal cancer – preliminary results of nonrandomized trial


Authors: D. Langer 1;  J. Kalvach 1;  I. Tučková 2;  J. Pudil 1;  K. Menclová 1;  M. Ryska 1
Authors‘ workplace: Chirurgická klinika 2. LF Univerzity Karlovy a ÚVN, Praha přednosta: prof. MUDr. M. Ryska, CSc. 1;  Oddělení patologie ÚVN – Vojenská fakultní nemocnice Praha primář: MUDr. P. Hrabal 2
Published in: Rozhl. Chir., 2015, roč. 94, č. 12, s. 526-530.
Category: Original articles

Overview

Introduction:
The incidence of colorectal cancer (CRC) in the Czech Republic is reported to be one of the highest on the global scale. Radical tumor removal has been observed to be the most effective part in the context of current multimodal therapy. The authors present their preliminary results of robotic assisted treatment of rectal carcinoma (RC).

Method:
The observed group includes 61 patients who underwent robotic assisted treatment for rectal cancer. The data were collected prospectively in the last 31 patients. Analyses were conducted on epidemiological data, perioperative outcomes, complications and oncological results.

Results:
Robotic assisted treatment of RC was performed in 61 patients: 34 men and 27 women, mean age of 62 years (33–80). Neoadjuvant oncological treatment was indicated in 46% of the patients. Average blood loss was 187 ml, transfusions were administered in three cases. Conversion to open procedure was performed 6 times, and 16 patients had postoperative complications. Anastomotic leak was observed in 10% of the patients, and 4 patients undewent surgical treatment. No patient died. Local recurrence of the cancer was diagnosed in 3 (5%) patients. The quality of mesorectal excision (ME) and the circumferential resection margin [(y)pCRM] have been determined in 27 patients since 2013. Positive (y)pCRM was recorded in two cases and incomplete ME was observed in 25.8% of the patients.

Conclusion:
Surgical treatment for RC is pivotal in multimodal therapy. Our preliminary results are similar to the conclusions in other published studies. The da Vinci robotic system is a safe manipulator in the treatment of RC and provides indisputable benefits to the surgeon when operating in the narrow pelvic space. However, the benefits of robotic treatment in abdominal surgery are yet to be evaluated in patients (with respect to long-term results, sufficient number of patients or a high EBM level of evidence). The high purchase price of the robotic device, individual instruments with equipment and non-systemic compensation constitute a significant hindrance that prevents wider use of the robotic system in the treatment of RC and other abdominal malignancies in the Czech Republic.

Key words:
rectal cancer – surgical treatment – da Vinci robotic system


Sources

1. www.svod.cz

2. Langer D, Pudil J, Ryska M. Robotická laparoskopická cholecystektomie. Rozhl Chir 2006;85:450−4.

3. Langer D, Pudil J, Rudiš J, et al. Přínos robotického systému da Vinci v abdominální onkochirurgii – naše předběžné výsledky. Rozhl Chir 2013;92:85–90.

4. Hoch J. Chirurgická léčba kolorektálního karcinomu. Rozhl Chir 2012;91:48–52.

5. Ryska M, Langer D. Chirurgická léčba kolorektálního karcinomu. Onkologie 2013;7:179–82.

6. Dušek L, Mužík J, Malúšková D, et al. Czech cancer care in numbers 2008−2009. Praha, Grada Publishing 2009.

7. How P, Shihab O, Tekkis P, et al. A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol 2011;20:149−55.

8. Nelson H, Petreli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. Journal of National Cancer Institute 2001;93:583−96.

9. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 2008;26:303−12.

10. Titu LV, Tweedle E, Rooney PS. High tie of the inferior mesenteric artery in curative surgery for left colonic and rectal cancers: a systematic review. Dig Surg 2008;25:148−57.

11. Lykke J, Jess P, Roikjaer O. A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment: Results from a national cohort study. Int J Colorectal Dis 2015;30:347–51.

12. Nagtegaal ID, van de Velde CJ, Marijnen CA, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729−34.

13. Rawlings AL, Woodland JH, Crawford DL. Telerobotic Surgery for right and sigmoid colectomies: 30 consecutive cases. Surg Endosc 2006;20:1713−8.

14. Baik SH, Ko YT, Kang CM, et al. Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc 2008;22:1601−8.

15. Baek JH, Pastor C, Pigazzi A. Robotic and laparoscopic total mesorectal exciton for rectal cancer: a case-matched study. Surg Endosc 2011;25:521−5.

16. D’Annibale A, Pernazza G, Monsellato I, et al. Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc 2013;27:1887–95.

17. Leong QM, Son DN, Cho JS, et al. Robot-assisted intersphincteric resection for low rectal cancer: technique and short-term outcome for 29 consecutive patients. Surg Endosc 2011;25:2987−92.

18. Atallah S, Martin-Perez B, Pinan J, et al. Robotic transanal total mesorectal excision: a pilot study. Tech Coloproctol 2014;18:1047–53.

19. Baek SJ, Kim SH, Cho JS, et al. Robotic versus conventional laparoscopic surgery for rectal cancer: A cost analysis from a single institute in Korea. World J Surg,2012;36:2722−9.

20. Ferko A, Örhalmi J, Nikolov DH, et al. Radikalita resekční léčby pro karcinom rekta (Analýza prediktivních faktorů spojených s nekompletní mezorektální excizí.) Rozhl Chir 2013;92:12−8.

Labels
Surgery Orthopaedics Trauma surgery
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#